SEC 13F Intelligence

Commodore Capital LP / NRIX

Commodore Capital LP’s Nurix Therapeutics Inc Position

Does Commodore Capital LP own Nurix Therapeutics Inc (NRIX)? Yes — 2.27M shares worth $35M (+2.04% of its 13F portfolio) as of Q1 2026.

Position Value
$35M
Q1 2026
Shares
2.27M
% of Portfolio
+2.04%
Quarters Held
7
currently held

Position History NRIX

Reported value by quarter
Q3 ’24: $37MQ3 ’24Q4 ’24: $57MQ4 ’24Q1 ’25: $47MQ1 ’25Q2 ’25: $45MQ2 ’25Q3 ’25: $35MQ3 ’25Q4 ’25: $43MQ4 ’25Q1 ’26: $35MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.27M$35M+2.04%
Q4 20252.27M$43M+2.87%
Q3 20253.78M$35M+1.71%
Q2 20253.95M$45M+3.17%
Q1 20253.98M$47M+3.48%
Q4 20243.00M$57M+4.14%
Q3 20241.65M$37M+2.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Commodore Capital LP’s full portfolio or all institutional holders of NRIX.